UNIVERSITATSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAT MAINZ

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 6161
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 5250
 
 
 
C07K PEPTIDES 3133
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 2123
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 2204
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
 
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 1239
 
 
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 1153
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0276,681 METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCEROct 19, 15Sep 28, 17[A61K, C12Q, G01N, C07K]
2017/0014,474 SCREENING METHOD FOR THE IDENTIFICATION OF AGENTS CAPABLE OF ACTIVATING CD4+CD25+ REGULATORY T-CELLS THROUGH INTERACTIONS WITH THE HIV-1 GP120 BINDING SITE ON CD4Oct 05, 16Jan 19, 17[A61K, C12N]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9364459 3-(indolyl)- or 3-(azaindolyl)- 4-arylmaleimide derivatives for use in the treatment of colon and gastric adenocarcinomaDec 10, 10Jun 14, 16[A61K, A61P]
9295457 Balloon catheter system for sealing puncture points in body cavities, hollow organs or in percutaneous systems in mammalsApr 20, 11Mar 29, 16[A61B, A61M]
9139639 Polynucleotides encoding an intracellular segment of CD40 and a constant region of an immunoglobulin heavy chainDec 16, 14Sep 22, 15[C12N, C07K]
8945923 Antigen-specific clonal expansion of B cellsOct 29, 10Feb 03, 15[A01N, C12N, C07K]
8557533 Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4Jan 30, 08Oct 15, 13[A61K, C12Q, C12N, G01N]

Expired/Abandoned/Withdrawn Patents

  • No Patents to Display

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.